Methotrexate is a strong medicine. The FDA approved it to treat adults with severe, disabling psoriasis that cannot be controlled with medicine applied to the skin or light treatments. Methotrexate ...

Please provide your email address to receive an email when new articles are posted on . Low-dose methotrexate did not relieve pain or reduce synovitis in inflammatory knee OA. The findings do not ...

Arthritis is a common condition that causes pain and inflammation in joints and can drastically impact the quality of a person's life. In the UK, millions of people have arthritis or other, similar ...

Greater risks of toxic effects were found at higher methotrexate doses and lower eGFR. Older patients with chronic kidney disease (CKD) starting low-dose methotrexate rather than hydroxychloroquine ...

Arthritis is a widespread condition causing pain and inflammation in joints, significantly impacting an individual's quality of life. In the UK, as per NHS data, millions suffer from arthritis or ...

Please provide your email address to receive an email when new articles are posted on . Methotrexate and low-dose prednisone combination allowed complete hair regrowth in up to 31% of patients. Only ...

Indication(s): Chronic gout in adult patients refractory to conventional therapy. The expanded approval was based on data from the phase 4 MIRROR trial, which evaluated Krystexxa plus methotrexate in ...

There seems to be both hope and uncertainty regarding the use of weekly methotrexate in giant cell arteritis (GCA) patients who need to limit their glucocorticoid use. While well done clinical trials ...

New research presented at ACR Convergence, the American College of Rheumatology's annual meeting, shows that tuberculosis (TB) screening and ongoing clinical care is needed for people on methotrexate ...